ARGENICA THERAPEUTICS
Who is ARGENICA THERAPEUTICS?
Argenica Therapeutics(ASX: AGN) is developing novel therapeutics to reduce brain tissue death after stroke and other types of brain injury and neurodegenerative diseases to improve patient outcomes. Stroke is the leading cause of death and disability worldwide and the economic costs of treatment a...See more
Industry & Specialities
Pharmaceuticals
Manufacturing
Countries of Operation
Australia
Headquarters:
Australia
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2019 (7 years)
Address:
NEDLANDS, PERTH, WESTERN AUSTRALIA 6009, AU
Employees by Department
- IT / Product (1)
- The Rest (6)
- Total (7)
Key Decision Makers
Emma Waldon
CFO & Company Secretary
Meghan Thomas
Head of Clinical Development
Paul Bailey
Clinical Advisory Committee
Liz Dallimore
CEO & Managing Director
Insight
Signals
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Employees by Seniority
C-level
2employees
Senior
0employees
Non-managers
3employees
Financials
LOW
spending power
Funding Status
Private
Associated Legal Entities
0 entities
Discover More Companies
Lookalike companies
Similar industry
Featured Lists
- Fast Growing SMEs
- Companies with Recent Funding > 100K
- Companies with High Spending Power
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has ARGENICA THERAPEUTICS been operating for?
- What is the funding status of ARGENICA THERAPEUTICS?
- Where is ARGENICA THERAPEUTICS's headquarter?
- What ARGENICA THERAPEUTICS's spending power?
- Does ARGENICA THERAPEUTICS have a presence in the domain it operates in?